In our previous column, we presented evidence of the harmful effects of the excessive amount of protein that is usually part of the standard animal-based diet that most of our people now consume. In this column, we will focus on another harmful effect of an animal-based diet that typically includ.
The update includes a recommended triple therapy with belimumab as a first line treatment for class III or IV lupus nephritis following the approvals of belimumab and voclosporin.
SEOUL, South Korea (BUSINESS WIRE) A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim results of phase 3 clinical trial of GX-E4 (Efepoetin alfa), a candidate for CKD (Chronic Kidney Disease) induced ane.